Mass General Brigham · 7 hours ago
Postdoctoral Fellow The Brain Tumor Immunotherapy Laboratory
Mass General Brigham is a not-for-profit organization dedicated to advancing patient care, research, and community service. They are seeking a postdoctoral fellow for the Brain Tumor Immunotherapy Laboratory to help develop novel experimental cellular immunotherapies for cancers such as glioblastoma, involving in vitro and in vivo experiments and scientific report writing.
Health CareHome Health CareMedical
Responsibilities
Designing and producing CAR T cells and other immunotherapies
Leading in vitro & in vivo experiments
Analyzing data
Playing a major role in writing and preparing scientific reports for publication
Mentoring junior lab members
Participating in training of and collaboration with visiting researchers
Qualification
Required
PhD or MD with focus in immunology, oncology, neurology/neuroscience, cell therapy, molecular biology, or a related discipline
Ability to work independently and contribute significantly to scientific writing and manuscripts
Meticulous attention to detail and lab management skills
Excellent communication skills and fluency in English
Preferred
Direct experience with CAR T cells, in vitro immunologic assays, flow cytometry, and murine tumor models is highly desirable
Experience with single-cell RNA-sequencing, spatial biology/transcriptomics, or computational/bioinformatic approaches is a plus
Prior authorship of peer-reviewed publications
Company
Mass General Brigham
Mass General Brigham specializes in providing medical treatments and health diagnostics services.
H1B Sponsorship
Mass General Brigham has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (77)
2024 (61)
2023 (93)
2022 (70)
2021 (80)
2020 (29)
Funding
Current Stage
Late StageLeadership Team
Recent News
2026-01-22
2026-01-19
Company data provided by crunchbase